Additional file 2: Figure S2. of Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study
Tomoyuki Hayashi
Taro Yamashita
Takeshi Terashima
Tsuyoshi Suda
Hikari Okada
Yoshiro Asahina
Takehiro Hayashi
Yasumasa Hara
Kouki Nio
Hajime Sunagozaka
Hajime Takatori
Kuniaki Arai
Yoshio Sakai
Tatsuya Yamashita
Eishiro Mizukoshi
Masao Honda
Shuichi Kaneko
10.6084/m9.figshare.5722183.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_Figure_S2_of_Serum_cytokine_profiles_predict_survival_benefits_in_patients_with_advanced_hepatocellular_carcinoma_treated_with_sorafenib_a_retrospective_cohort_study/5722183
Comparison of serum IL-5, CXCL9, and VGEF-A levels between long survivors and non-long survivors in the 2 cohorts. (PDF 117 kb)
2017-12-19 05:00:00
Hepatocellular carcinoma
Sorafenib
Hepatic arterial infusion chemotherapy
Cytokine
Chemokine
Growth factor